Cargando…
Endogenous Opioid Levels Do Not Correlate With Itch Intensity and Therapeutic Interventions in Hepatic Pruritus
Background: Chronic pruritus affects up to 70% of patients with immune-mediated hepatobiliary disorders. Antagonists of the μ-opioid receptor (MOR) and agonists of the κ-opioid receptor (KOR) are used to treat hepatic itch, albeit with limited success. An imbalance between ligands of MOR and KOR rec...
Autores principales: | Düll, Miriam M., Wolf, Katharina, Vetter, Marcel, Dietrich, Peter, Neurath, Markus F., Kremer, Andreas E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079640/ https://www.ncbi.nlm.nih.gov/pubmed/33937284 http://dx.doi.org/10.3389/fmed.2021.641163 |
Ejemplares similares
-
Role of kappa‐opioid and mu‐opioid receptors in pruritus: Peripheral and central itch circuits
por: Kim, Brian S., et al.
Publicado: (2022) -
Pruritus: an overview. What drives people to scratch an itch?
por: Lavery, Michael Joseph, et al.
Publicado: (2016) -
Neuroimmune Mediators of Pruritus in Hispanic Scalp Psoriatic Itch
por: NATTKEMPER, Leigh A., et al.
Publicado: (2023) -
Cowhage-Induced Itch as an Experimental Model for Pruritus. A Comparative Study with Histamine-Induced Itch
por: Papoiu, Alexandru D. P., et al.
Publicado: (2011) -
Effectiveness of a Multidisciplinary Itch Clinic in the Management of Chronic Pruritus
por: Michelle, Liang Weiting, et al.
Publicado: (2015)